From The Health Forum NZ @ Facebook This week Medsafe announced a new form of "active surveillance" for CV V adverse reactions.This will involve texting a random sample of 10% of V recipients, at various time intervals, soliciting information about reactions.I am pleased to see this for of surveillance added….while also wondering why we waited […]

Read more of this post